Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Fampridine-D4

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Fampridine-D4

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Acorda’s awful bad week gets worse as FDA hands execs another delay on Inbrija
    Acorda’s awful bad week gets worse as FDA hands execs another delay on Inbrija

    13 Sep 2018

    // John Carroll ENDPTS

    https://endpts.com/acordas-awful-no-good-just-plain-bad-week-gets-worse-as-fda-hands-execs-another-delay-on-inbrija-battered-shares-tumble-again/?utm_medium=email&utm_campaign=564%20Thu%2091318%20Genentech%20science%20crew%20spotlights%20a%20breakthrough%20SEC%20alleges%20hedge%20fund%20player%20lied%20in%20biotech%20short%20attack&utm_content=564%20Thu%2091318%20Genentech%20science%20crew%20spotlights%20a%20breakthrough%20SEC%20alleges%20hedge%20fund%20player%20lied%20in%20biotech%20short%20attack+CID_c4f98919d8f5ac4097aa265dd3bfc0c5&utm_source=ENDPOINTS%20emails&utm_term=Acordas%20awful%20no%20good%20just%20plain%20bad%20week%20gets%20worse%20as%20FDA%20hands%20execs%20another%20delay%20on%20Inbrija%20%20battered%20shares%20tumble%20again

    John Carroll ENDPTS
    13 Sep 2018
    Share Share
    U.S. appeals court invalidates Acorda patents on MS drug
    U.S. appeals court invalidates Acorda patents on MS drug

    11 Sep 2018

    // Jan Wolfe CNBC

    https://www.cnbc.com/2018/09/10/reuters-america-update-1-u-s-appeals-court-invalidates-acorda-patents-on-ms-drug.html

    Jan Wolfe CNBC
    11 Sep 2018
    Share Share
    Acorda shares crater after court dashes hopes for salvaging Ampyra patents
    Acorda shares crater after court dashes hopes for salvaging Ampyra patents

    10 Sep 2018

    // John Carroll ENDPTS

    https://endpts.com/acorda-shares-crater-after-appeals-court-dashes-remaining-hopes-for-salvaging-ampyra-patents/

    John Carroll ENDPTS
    10 Sep 2018
    Share Share
    Acorda inks Ampyra generic pacts as Ampyra appeal pends
    Acorda inks Ampyra generic pacts as Ampyra appeal pends

    06 Aug 2018

    // Carly Helfand FIERCE PHARMA

    https://www.fiercepharma.com/pharma/acorda-inks-mylan-settlement-pact-as-it-waits-for-ampyra-appeal-news

    Carly Helfand FIERCE PHARMA
    06 Aug 2018
    Share Share
    After resisting a push to the auction block, Acorda shares shoot up
    After resisting a push to the auction block, Acorda shares shoot up

    05 Jan 2018

    // John Carroll END POINTS

    https://endpts.com/after-resisting-a-push-to-the-auction-block-acorda-preps-for-a-sale-and-shares-shoot-up-report/

    John Carroll END POINTS
    05 Jan 2018
    Share Share
    Troubled Acorda hurries to bar the door against a takeover attempt
    Troubled Acorda hurries to bar the door against a takeover attempt

    02 Sep 2017

    // John Carroll ENDPTS

    https://endpts.com/troubled-acorda-hurries-to-bar-the-door-against-a-takeover-attempt/

    John Carroll ENDPTS
    02 Sep 2017
    Share Share